thymidine has been researched along with End Stage Liver Disease in 3 studies
End Stage Liver Disease: Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In our study, long-term telbivudine therapy is associated with a sustained improvement of renal function in patients with hepatitis B virus infection after living donor liver transplant." | 7.85 | A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant. ( Chen, YL; Hsieh, CE; Ko, CJ; Lin, CC; Lin, KH; Lin, PY; Ming, YZ, 2017) |
| "In our study, long-term telbivudine therapy is associated with a sustained improvement of renal function in patients with hepatitis B virus infection after living donor liver transplant." | 3.85 | A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant. ( Chen, YL; Hsieh, CE; Ko, CJ; Lin, CC; Lin, KH; Lin, PY; Ming, YZ, 2017) |
| "352 patients with acute-on-chronic hepatitis B liver failure including 175 cases of low HBV viral load and 177 cases of high HBV viral load were enrolled into this study." | 2.75 | [Efficacy of antiviral treatment on patients with acute-on-chronic hepatitis B liver failure with low viral load]. ( Cao, H; Chen, LB; Chen, N; Li, G; Shu, X; Xu, QH; Zhang, K; Zhang, YF, 2010) |
| "Lamivudine was switched to telbivudine." | 1.42 | Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy. ( Akarca, US; Bademkiran, F; Duman, S; Ersoz, G; Gunsar, F; Karasu, Z; Kose, T; Ozutemiz, O; Sozbilen, M; Turan, I; Yapali, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Turan, I | 1 |
| Yapali, S | 1 |
| Bademkiran, F | 1 |
| Kose, T | 1 |
| Duman, S | 1 |
| Sozbilen, M | 1 |
| Gunsar, F | 1 |
| Ersoz, G | 1 |
| Akarca, US | 1 |
| Ozutemiz, O | 1 |
| Karasu, Z | 1 |
| Lin, KH | 1 |
| Chen, YL | 1 |
| Lin, PY | 1 |
| Hsieh, CE | 1 |
| Ko, CJ | 1 |
| Lin, CC | 1 |
| Ming, YZ | 1 |
| Chen, LB | 1 |
| Cao, H | 1 |
| Zhang, YF | 1 |
| Shu, X | 1 |
| Chen, N | 1 |
| Zhang, K | 1 |
| Li, G | 1 |
| Xu, QH | 1 |
1 trial available for thymidine and End Stage Liver Disease
| Article | Year |
|---|---|
[Efficacy of antiviral treatment on patients with acute-on-chronic hepatitis B liver failure with low viral load].
Topics: Adult; Antiviral Agents; End Stage Liver Disease; Female; Guanine; Hepatitis B, Chronic; Humans; Lam | 2010 |
2 other studies available for thymidine and End Stage Liver Disease
| Article | Year |
|---|---|
Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.
Topics: Aged; Antiviral Agents; Diabetes Mellitus; Drug Substitution; End Stage Liver Disease; Female; Glome | 2015 |
A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant.
Topics: Adult; Aged; Antiviral Agents; Biomarkers; Creatinine; Cross-Sectional Studies; End Stage Liver Dise | 2017 |